Skip to main content
. 2017 Jan 5;18(1):6–17. doi: 10.3348/kjr.2017.18.1.6

Fig. 1. Timeline of events in lung cancer molecular targeted therapies.

Fig. 1

ALK = anaplastic lymphoma kinase, EGFR = epidermal growth factor receptor, FDA = Food and Drug Administration